(Q30145547)

6 June 2017

1 reference

title

Newer Vaccines against Mosquito-borne Diseases (English)

1 reference

6 June 2017

0 references

Anju Aggarwal

1

1 reference

6 June 2017

Neha Garg

series ordinal

2

1 reference

6 June 2017

publication date

31 May 2017

1 reference

Indian Journal of Pediatrics

6 June 2017

published in

1 reference

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

6 June 2017

cites work

1 reference

12 December 2020

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

1 reference

12 December 2020

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.

1 reference

12 December 2020

Vaccination Against Dengue: Challenges and Current Developments

1 reference

12 December 2020

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity

1 reference

12 December 2020

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

12 December 2020

Vaccines in development against West Nile virus

1 reference

12 December 2020

Dengue vaccine: WHO position paper, July 2016 - recommendations

1 reference

12 December 2020

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Dengue vaccines approach the finish line

1 reference

12 December 2020

Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity

1 reference

12 December 2020

Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013.

1 reference

12 December 2020

CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety

1 reference

12 December 2020

Vaccine Development for Zika Virus-Timelines and Strategies

1 reference

12 December 2020

Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.

1 reference

12 December 2020

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis

1 reference

12 December 2020

The global burden of dengue: an analysis from the Global Burden of Disease Study 2013

1 reference

12 December 2020

Vaccines against malaria

1 reference

12 December 2020

Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine

1 reference

12 December 2020

A chikungunya fever vaccine utilizing an insect-specific virus platform

1 reference

12 December 2020

Chikungunya virus and prospects for a vaccine

1 reference

12 December 2020

Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka

1 reference

12 December 2020

A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers

1 reference

12 December 2020

Emergency department management of mosquito-borne illness: malaria, dengue, and West Nile virus.

1 reference

12 December 2020

Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15-18 Months of Age in Mexico: A Randomized Trial

1 reference

12 December 2020

An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody

1 reference

12 December 2020

10.1007/S12098-017-2383-4

Identifiers

DOI

1 reference

Dimensions Publication ID

6 June 2017

1085722710

0 references

1 reference